07:00 , Jul 5, 2010 |  BC Week In Review  |  Company News

Jiangxi Aiqilin Pharmaceuticals, Uluru deal

Uluru granted Jiangxi rights to commercialize Altrazeal in China, Hong Kong, Macau and Taiwan. Uluru already markets the antimicrobial dressing incorporating the company's Nanoflex nanoparticle aggregate technology in the U.S. for wound management. Uluru...